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INTRODUCTION
In December 2019, the novel coronavirus disease 2019 
(COVID-19) outbreak occurred in Wuhan, China. As of March 
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Objective: We investigated the prevalence of pneumonia in novel coronavirus disease 2019 (COVID-19) patients using chest 
radiographs to identify the characteristics of those with initially negative chest radiographs, who were positive for pneumonia 
on follow-up. 
Materials and Methods: Retrospective cohort data of 236 COVID-19 patients were reviewed. Chest radiography was performed 
on admission, with serial radiographs obtained until discharge. The ‘positive conversion group’ was defined as patients whose 
initial chest radiographs were negative but were positive for pneumonia during follow-up. Patients with initially positive chest 
radiographs were defined as the ‘initial pneumonia group.’ Patients with negative initial and follow-up chest radiographs 
were defined as the ‘non-pneumonia group.’ Clinical and laboratory findings were compared between groups, and predictors 
of positive conversion were investigated.
Results: Among 236 patients, 108 (45.8%) were in the non-pneumonia group, 69 (29.2%) were in the initial pneumonia group, 
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group’ were older, had higher C-reactive protein (CRP) and lactate dehydrogenase levels, and lower absolute lymphocyte counts 
than those in the ‘non-pneumonia group’ (all p < 0.001). Among patients with negative initial chest radiographs, age ≥ 45 
years (odds ratio [OR]: 3.93, 95% confidence interval [CI]: 1.76–8.75, p = 0.001), absolute lymphocyte count < 1500 cells/µL 
(OR: 2.25, 95% CI: 1.03–4.89, p = 0.041), and CRP > 0.5 mg/dL (OR: 3.91, 95% CI: 1.54–9.91, p = 0.004) were independent 
predictors for future development of pneumonia. 
Conclusion: More than a half of COVID-19 patients initially had normal chest radiographs; however, elderly patients (≥ 45 
years of age) with abnormal laboratory findings (elevated CRP and low absolute lymphocyte counts) developed pneumonia 
on follow-up radiographs. 
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2020, approximately 80000 people were infected in China, 
with more than 3100 deaths reported from the infection 
(1). The disease spread rapidly to neighboring countries. In 
Korea, the first COVID-19 patient was diagnosed on January 
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transcriptase-polymerase chain reaction of sputum or nasal 
secretions in other screening clinics such as public health 
centers. In this cohort, 142 patients (60.2%) belonged to 
a certain religious group, where a community infection was 
suspected. Most of the patients had mild symptoms such as 
fever, sore throat, myalgia, chills, headache, sputum, cough, 
rhinorrhea, and dyspnea, not requiring intensive care (such 
as ventilator use) at the time of admission. Twelve patients 
were asymptomatic (5.1%) and had been diagnosed using 
screening tests based on their contact history with infected 
persons. Three patients (1.3%) were not able to remember 
the exact date of symptom onset. For two of the patients 
(0.8%), it was not possible to specify symptom type 
because of severe communication difficulties. 
Clinical Data Extraction
Patients’ demographic data, underlying diseases, 
symptom types, and symptom onset dates were reviewed 
and collected. Initial laboratory results at the time of 
admission, including complete blood count with differential 
counts, C-reactive protein (CRP), and lactate dehydrogenase 
(LDH) levels were obtained. Data on clinical severity, such 
as the occurrence of severe pneumonia according to the 
WHO criteria, admission to the intensive care unit (ICU), 
and death due to worsening of COVID-19, were obtained. 
Chest Radiograph
In our COVID-19 cohort hospital, the entire premises 
was designated as a contaminated isolation zone. The 
radiographers wore personal protective equipment to 
acquire chest radiographs of COVID-19 patients. A digital 
radiography (INNOVISION, DK Medical systems) system was 
used. All patients underwent initial chest radiography in 
the erect position (posterior-anterior projection) on the day 
of admission, and follow-up chest radiographs were taken 
every two or three days until discharge. All images were 
reviewed by two chest radiologists (with 9 and 16 years 
of experience, respectively), who were blinded to previous 
images and clinical information. In cases of inter-reader 
discrepancies, a consensus was reached through discussion. 
Patients whose chest radiographs were initially negative 
on admission, but subsequently developed pneumonia 
during hospitalization, were classified as the ‘positive 
conversion group.’ Patients with pneumonia detected on 
the initial chest radiographs were classified as the ‘initial 
pneumonia group,’ and those patients with no evidence of 
pneumonia on initial and follow-up chest radiographs during 
20, 2020, and in February, the number of COVID-19 patients 
had increased rapidly, particularly among a certain religious 
group in Daegu city (2, 3). On March 11, 2020, the World 
Health Organization (WHO) declared the COVID-19 outbreak 
a pandemic (4).
The Fleischner Society states that imaging is indicated 
in patients at risk of disease progression, with a worsening 
respiratory status (5). Therefore, it is important to identify 
the characteristics of those who develop pneumonia 
and need chest radiographs in a resource-constrained 
environment.
Several recent studies have reported that chest 
radiographs, or even computed tomography (CT), may 
appear normal in the early phases of COVID-19 infection (6, 
7). Interestingly, a few studies reported that some COVID-19 
infected patients with normal CT results, eventually develop 
pneumonia on follow-up CT scans (7, 8). The reported 
rates of mortality and receipt of intensive care are 4.6% 
and 26%, respectively, in patients who develop pneumonia 
(9). However, patient characteristics associated with the 
development of pneumonia among patients who initially 
had normal findings in the early stages, remains unclear. 
In this emergent pandemic situation, all patients infected 
with COVID-19 cannot be admitted due to insufficient 
hospital beds. Thus, it is important to predict who will 
develop pneumonia and require treatment.
Therefore, this study aimed to investigate the prevalence 
of pneumonia in COVID-19 patients using chest radiographs, 
and identify the characteristics of those who had negative 
chest radiographs initially, who were then positive for 
pneumonia on follow-up chest radiographs. 
MATERIALS AND METHODS
Patients
This single cohort retrospective study was approved by 
the Institutional Review Board of Keimyung University 
Dongsan Hospital (2020-04-065), and the requirement 
to obtain informed patient consent was waived. Our 
institution was designated a cohort hospital for admitting 
patients with COVID-19. A total of 236 patients (67 
men, 169 women; 46.5 ± 15.3 years old) diagnosed with 
COVID-19 were admitted to the hospital between February 
22, 2020 and February 27, 2020. Since it was a cohort 
hospital, and only COVID-19 patients were hospitalized, 
no patients were excluded. All patients were diagnosed 




hospitalization, were classified as the ‘non-pneumonia 
group.’ The presence of a lesion on a chest radiograph was 
recorded when opacities were seen. To avoid false positives 
in the pneumonia group, increased opacities on chest 
radiographs of 57 patients (44.5%) were confirmed as 
pneumonia on CT scans taken during hospitalization; in the 
remaining 71 patients (55.5%) pneumonia was determined 
through improvement, or new development, of opacities 
during hospitalization. The presence and location of 
pneumonia on the initial and all follow-up chest radiographs 
were analyzed, and the radiograph fields were divided into 
six zones: upper, middle, and lower lung zones on each 
side. The extent of pneumonia in each zone was scored from 
0 to 4 (score 0: no evidence of pneumonia, score 1: 1–25% 
involvement of pneumonia, score 2: 26–50% involvement 
of pneumonia, score 3: 51–75% involvement of pneumonia, 
and score 4: > 75% involvement of pneumonia) (10). The 
scores of the 6 lung zones were added, with scores ranging 
0 to 24. 
Statistical Analysis
Categorical variables are presented as numbers with 
percentages, and continuous variables are presented as 
means and standard deviations. Differences between 
groups were analyzed using the chi-square or Fisher’s exact 
tests for categorical variables and the ANOVA or Kruskal-
Wallis test for continuous variables. Post-hoc analysis was 
performed using the Bonferroni method. The cut-off value 
for continuous variables was set based on receiver operating 
characteristic curve analysis for positive conversion. 
Logistic regression analyses were used to find clinical 
predictors of positive conversion of chest radiographs 
among patients with initially negative chest radiographs. 
Factors with p < 0.1 were entered into multivariable 
analysis. Spearman correlation analysis was performed to 
identify the correlation between the pneumonia scores 
on chest radiographs and the clinical variables. Statistical 
analyses were performed using SPSS version 25.0 (IBM 




A total of 236 patients were included in the study and the 
entire follow-up period was 80 days. During hospitalization, 
21 patients (8.9%) progressed to severe pneumonia and 
received inhalation oxygen support and 11 patients (4.7%) 
were admitted to the ICU. Among the latter, eight patients 
were eventually transferred to other tertiary hospitals due 
to lack of ICU space. One transferred patient (0.4%) died 
due to acute respiratory failure.
Initial and Follow-Up Chest Radiographs
All COVID-19 patients had undergone chest radiography 
on the day of admission, or the following day. Among 236 
patients, 108 (45.8%) were in the non-pneumonia group, 
69 (29.2%) were in the initial pneumonia group, and 59 
(25%) were in the positive conversion group (Fig. 1). The 
majority (11/12, 92%) of asymptomatic patients showed 
negative findings on the initial chest radiographs; however, 
three patients eventually showed pneumonia on follow-up 
chest radiographs, with symptom presentation. Among the 
total 236 initial chest radiographs, there were 11 discrepant 
cases between readers, and consensus was achieved by 
reviewing the cases in conjunction. 
Clinical Features between Groups (Non-Pneumonia vs. 
Positive Conversion vs. Initial Pneumonia Groups)
The clinical characteristics of each group are summarized 
in Table 1. The mean age was significantly higher in the 
positive conversion and initial pneumonia groups than in the 
non-pneumonia group (mean, 51.5 years vs. 54.9 years vs. 
38.5 years; p < 0.001). Chills were observed significantly 
more often in the initial pneumonia group than in the 
non-pneumonia group (p = 0.009). Myalgia was observed 
significantly more often in the positive conversion and 
initial pneumonia groups than in the non-pneumonia group 
Fig. 1. Study population. Among 236 patients, 108 (45.8%) were in 
non-pneumonia group, 69 (29.2%) were in initial pneumonia group, 
and 59 (25%) were in positive conversion group. N = number of 
patients, COVID-19 = novel coronavirus disease 2019
COVID-19 patients (n = 236)
Initial
chest radiograph (-)
(n = 167, 70.8%)
Initial
chest radiograph (+)













day. Initial CRP (median, 1.3 mg/dL vs. 0.3 mg/dL vs. 0.1 
mg/dL, p = 0.001) and LDH levels (median, 508 U/L vs. 
448 U/L vs. 391 U/L, p < 0.001) were significantly higher 
and the absolute lymphocyte count (median 1260.4 cells/
(p = 0.010). Initial pneumonia and positive conversion 
groups had significantly more hypertension than the non-
pneumonia group (both, p < 0.05). In all patients, blood 
tests were performed on the day of admission or the next 




Positive Conversion Group 
(n = 59)
Initial Pneumonia Group 
(n = 69)
P
Sex (male/female) 32/76 16/43 19/50 0.947
Age (years)*† 38.5 ± 13.4 51.5 ± 14.7 54.9 ± 12.4 < 0.001
Vital sign at time of admission
Body temperature (°C)*† 37.0 ± 0.4 37.2 ± 0.6 37.4 ± 0.7 < 0.001
Pulse rate (bpm) 82.5 ± 15.7 84.3 ± 15.8 87.0 ± 20.9 0.245
Respiratory rate (bpm)* 18.5 ± 1.7 18.7 ± 1.4 20.7 ± 10.4 0.031
Systolic blood pressure (mm Hg)†‡ 127.5 ± 17.3 140.9 ± 22.9 130.2 ± 18.5 < 0.001
Saturation (%)* 98.1 ± 1.2 97.4 ± 1.3 95.7 ± 4.7 0.021
Symptom at time of admission
Asymptomatic 8 (7.5) 3 (5.1) 1 (1.5) 0.220
Fever 49 (45.4) 31 (52.5) 43 (62.3) 0.061
Chills* 30 (27.8) 25 (42.4) 32 (46.4) 0.019
Cough 57 (52.8) 35 (59.3) 41 (59.4) 0.496
Sputum 49 (45.4) 28 (47.5) 33 (47.8) 0.791
Rhinorrhea 26 (24.1) 17 (28.8) 14 (20.3) 0.489
Sore throat 36 (33.3) 21 (35.6) 16 (23.2) 0.228
Myalgia*† 38 (35.2) 39 (56.5) 33 (55.9) 0.010
Headache 51 (47.2) 30 (50.8) 31 (44.9) 0.738
Diarrhea 25 (23.1) 19 (32.2) 19 (29.0) 0.353
Dyspnea 6 (5.6) 7 (11.9) 9 (13.2) 0.175
Chest pain 7 (6.5) 3 (5.1) 5 (7.4) 0.942
Underlying disease
Hypertension*† 6 (5.6) 11 (18.6) 13 (19.1) 0.009
Diabetes 3 (2.8) 6 (10.2) 7 (10.3) 0.057
Hyperlipidemia* 3 (2.8) 2 (3.4) 9 (13.2) 0.017
Cardiovascular disease 2 (1.9) 2 (3.4) 2 (2.9) 0.767
Cerebrovascular disease 0 (0) 0 (0) 2 (2.9) 0.145
Chronic kidney disease 0 (0) 0 (0) 0 (0) NA
Malignancy 1 (0.9) 2 (3.4) 3 (4.4) 0.328
Initial laboratory findings
WBC count (x 103/µL) 4442.0 ± 1340.9 4290.3 ± 1179.4 4441.0 ± 1531.7 0.762
Absolute neutrophil count (µL) 2065.0 (1370.0–2840.0) 2150.0 (1720.0–2880.0) 2440.0 (1700.0–3230.0) 0.117
Absolute lymphocyte count (cells/µL)*† 1645.7 (1458.7–1959.4) 1489.0 (1179.8–1771.3) 1260.4 (1040.0–1568.8) < 0.001 
CRP (mg/dL)*† 0.1 (0.03–0.10) 0.3 (0.20–0.70) 1.3 (0.3–2.9) 0.001
LDH (U/L)*†‡ 391.0 (349.5–464.5) 448.0 (398.0–524.0) 508.0 (425.0–622.0) < 0.001
Clinical severity
Severe pneumonia* 0 (0) 3 (5.1) 7 (10.1) 0.005
ICU admission*† 0 (0) 4 (6.8) 7 (10.1) 0.001
Death 0 (0) 0 (0) 1 (1.4) 0.297
Data are presented as number of patients (percentage), median (25–75th percentile), or mean ± standard deviation. *Significantly 
different between ‘non-pneumonia’ and ‘initial pneumonia group,’ †Significantly different between ‘non-pneumonia’ and ‘positive 
conversion group,’ ‡Significantly different between ‘positive conversion group’ and ‘initial pneumonia group.’ Bpm = beats per minute, 





µL vs. 1489.0 cells/µL vs. 1645.7 cells/µL; p < 0.001) was 
significantly lower in the initial pneumonia and positive 
conversion groups compared to the non-pneumonia 
group. The number of patients who progressed to severe 
pneumonia were highest in the initial pneumonia group (7 
patients, 10.1%) followed by the positive conversion group 
(3 patients, 5.1%). The number of patients admitted to 
the ICU was significantly higher in the initial pneumonia 
group (7 patients, 10.1%) and positive conversion group 
(4 patients, 6.8%) than in the non-pneumonia group (p = 
0.001). One death (1.4%) occurred in the initial pneumonia 
group. 
Predictors for Positive Conversion among the Patients 
with Initial Negative Chest Radiograph
Table 2 summarizes the results of univariable and 
multivariable analyses for finding predictors of positive 
conversion. On univariable analysis, age older than 45 
years (odds ratio [OR]: 5.83, 95% confidence interval [CI]: 
2.87–11.86, p < 0.001), underlying diseases including 
hypertension (OR: 3.74, 95% CI: 1.31–10.71, p = 0.014) 
and diabetes (OR: 3.82, 95% CI: 0.92-15.85, p = 0.065), 
absolute lymphocyte count of less than 1500 cells/µL (OR: 
2.38, 95% CI: 1.24–4.55, p = 0.009), CRP levels higher 
than 0.5 mg/dL (OR: 11.23, 95% CI: 5.30–23.80, p < 
0.001), and LDH levels higher than 430 U/L (OR: 2.19, 95 
CI%: 1.15–4.17, p = 0.018) were significant predictors for 
positive conversion. Symptoms and hyperlipidemia were not 
significant predictors of positive conversion.
On multivariable analysis, age older than 45 years 
(adjusted OR: 3.93, 95% CI: 1.76–8.75, p = 0.001), absolute 
lymphocyte counts of less than 1500 cells/µL (adjusted OR: 
2.25, 95% CI: 1.03–4.89, p = 0.041), and CRP level higher 
than 0.5 mg/dL (adjusted OR: 3.91, 95% CI: 1.54–9.91, p = 
0.004) were significant predictors for positive conversion 
(Fig. 2). However, hypertension, diabetes, and LDH levels 
were not significant predictors for positive conversion.
Timing of Chest Radiograph after Symptom Onset 
The time interval of chest radiographs taken after the 
initial symptom onset is summarized in Table 3. In the 
positive conversion group, the initial radiographs were 
obtained closer to symptom onset than that in patients 
who had pneumonia initially (positive conversion group; 
median, 5 days; 25–75th percentile; 3–7 days vs. initial 
pneumonia group; median, 6 days; 25–75th percentile; 4–9 
days; p = 0.008). In the positive conversion group, follow-
up chest radiographs showed pneumonia within a median 
of 4 days (25–75th percentile, 4–6 days) after the initial 
chest radiographs were obtained. As a result, the positive 
conversion group showed positive chest radiographs at a 
median of 10 days (25–75th percentile, 7–12 days) after 
symptom onset. 
In all pneumonia groups (n = 125, both initial pneumonia 
and positive conversion groups), chest radiographs became 
positive at a median of 8 days (25–75th percentile, 7–12 
days) after symptom onset (Fig. 3). 
Chest Radiograph Features 
The most common location of COVID-19 pneumonia was 
in both the lower zones (Table 4), and the median score of 
pneumonia was 3 (25–75th percentile score: 2–8) in the 
pneumonia groups (both, positive conversion and initial 
pneumonia groups). The radiographic pneumonia score was 
significantly associated with high CRP (rho = 0.447, p < 
0.001), high LDH (rho = 0.377, p < 0.001), low lymphocyte 
counts (rho = 0.245, p = 0.006), and old age (rho = 0.225, 
p = 0.011). The median score of the initial pneumonia 
group was significantly higher than that of the positive 
conversion group (median 5 score, 25–75th percentile, 
Table 2. Predictors of Positive Conversion in Patients with Initially Negative Chest Radiographs
Variates
Univariable Analysis Multivariable Analysis
OR (95% CI) P Adjusted OR (95% CI) P
Age ≥ 45 years old 5.83 (2.87–11.86) < 0.001 3.93 (1.76–8.75) 0.001
Hypertension 3.74 (1.31–10.71) 0.014 1.67 (0.48–5.75) 0.418
Diabetes 3.82 (0.92–15.85) 0.065 2.45 (0.48–12.53) 0.281
Hyperlipidemia 1.18 (0.19–7.29) 0.856
Symptom 1.55 (0.40–6.80) 0.529
Absolute lymphocyte count < 1500 cells/µL 2.38 (1.24–4.55) 0.009 2.25 (1.03–4.89) 0.041
CRP > 0.5 mg/dL 11.23 (5.30–23.80) < 0.001 3.91 (1.54–9.91) 0.004
LDH > 430 U/L 2.19 (1.15–4.17) 0.018 1.60 (0.73–3.51) 0.244




radiographs were associated with obtaining the images 
closer to symptom onset than in patients who showed 
pneumonia at the time of admission. Moreover, older age 
(≥ 45 years), high CRP (> 0.5 mg/dL), and low absolute 
lymphocyte count (< 1500 cells/µL) were the independent 
factors for future progression to pneumonia in patients with 
initial negative chest radiographs.
Several studies have shown that old age, underlying 
disease, elevated inflammatory indicators (CRP, LDH), 
and low absolute lymphocyte count are commonly related 
to poor prognosis in patients with COVID-19 (9, 11-13). 
Indeed, age and inflammatory indicators at the time of 
admission were significantly related to the occurrence of 
3–9.5 score vs. median 3 score, 25–75th percentile, 2–5 
score, p = 0.001). The median score of the ICU admitted 
patients was 12 (25–75th percentile: 9–14). The score of 
one patient who died was 16.
DISCUSSION
Our study revealed that a more than half of patients 
(70.8%) with COVID-19 showed initial negative chest 
radiographs; however, some patients (25% of the 
entire cohort) eventually progressed to show COVID-19 
pneumonia on follow-up radiographs within several days. 
In this positive conversion group, initial negative chest 
Table 3. Time Interval of Chest Radiographs between Groups 
Non-Pneumonia 
Group (n = 108)
Positive Conversion 
Group (n = 59)
Initial Pneumonia 
Group (n = 66)*
P
Symptom onset to initial radiograph (days)† 5 (3–6) 5 (3–7) 6 (4–9) 0.001
Interval between initial negative chest radiograph  
  to positive conversion (days)
NA 4 (4–6) NA NA
Symptom onset to positive conversion (days) NA 10 (7–12) NA NA
All pneumonia group (n = 125)
Symptom onset to positive chest radiograph (days) NA 8 (7–12) NA
Data are presented as median (25–75th percentile). *Three patients not able to remember the date of symptom onset, †Significantly 
different between ‘initial pneumonia’ and ‘positive conversion group’ and between ‘initial pneumonia’ and ‘non-pneumonia group.’
Fig. 2. Initial and follow-up chest radiographs in positive conversion group. 67-year-old woman with history of right mastectomy due to 
breast cancer. 
A. Normal initial chest radiograph on day 5 after symptom onset. In laboratory tests, inflammatory indicators including C-reactive protein (19.8 
mg/dL) and lactate dehydrogenase (906 U/L) were notably increased, and absolute lymphocyte count (591.6 cells/µL) was decreased. B. Follow-






later pneumonia when the initial chest radiographs were 
negative. Thus, an initial negative chest radiograph in 
a patient should not be considered conclusive for non-
progression to pneumonia in the subsequent days or weeks. 
In this study, the presence of pneumonia may have been 
dependent on the amount of time after symptom onset. In 
a recent study by Bernheim et al. (6), positive CT findings 
were related to symptom duration, with 56% of patients 
showing normal CT findings in the early (0–2 days) phase 
after symptom onset. Fang et al. (14) also reported that 
ground glass opacities (GGOs) were the main findings in 
the early stage of the disease as shown on a CT scan (0–4 
days), and that abnormal CT findings were most common 10 
days after the initial onset of symptoms. In our study, the 
patients in the positive conversion group had their initial 
chest radiographs taken earlier than those in the initial 
pneumonia group. Therefore, a negative chest radiograph at 
an early stage after symptom onset should not be concluded 
as the absence of pneumonia, especially in elderly patients 
with abnormal laboratory findings. Furthermore, in this 
study, the pneumonia presented at a median of 8 days after 
symptom onset in both pneumonia groups. Therefore, it 
is necessary to consider the patient’s symptom onset day 
and clinical condition when performing imaging studies in 
resource constrained environments. 
In our study, a follow-up chest radiograph became 
positive 4–6 days after an initial negative chest radiograph. 
Similarly, Pan et al. (7) and Yang et al. (15) also reported 
a positive CT scan 4 and 7 days following the initial 
negative scan, respectively. Therefore, we suggest follow-
up chest radiographs should be taken within 1 week for 
older patients and those with increased CRP and decreased 
lymphocyte counts in order to monitor for future pneumonia 
development. In our study, 45.8% of patients continued to 
have no evidence of pneumonia on chest radiographs until 
discharge; this is similar to the findings of a large scale 
study from China, which reported that 45.8% of non-severe 
patients and 23.3% of severe patients had no abnormalities 
on chest radiographs (13). The non-pneumonia group was 
characterized by younger age, normal laboratory findings, 
and fewer underlying diseases. 
Similar to the findings of previous reports, the most 
frequent radiographic findings of COVID-19 pneumonia in 
this study included bilateral consolidation and GGO with 
peripheral dominance (3, 14, 16). The radiographic score 
used in this study was significantly associated with age and 
abnormal laboratory findings. 
There are several limitations to this study. First, this study 
was conducted using chest radiographs obtained in the 
erect position in the posterior-anterior direction; therefore, 
the results may not be applicable to chest radiographs 
obtained in the anterior-posterior direction and supine 
position. Second, this study may have a selection bias, as 
most of the patients had non-severe disease and were from 
a particular religious community. Third, not all the chest 
radiographs were compared with chest CTs; therefore, the 
possibility of false-negative cases may exist. Fourth, we did 
not detail morphological features of chest radiographs, such 
as consolidation or GGOs. 
In conclusion, although a considerable proportion of 
Fig. 3. Time interval between initial symptom onset to positive 
chest radiograph in patients with pneumonia (both initial 
pneumonia and positive conversion group, n = 125*). Positive 
chest radiograph was seen in median of 8 days (25–75th percentile, 
7–12 days) after symptom onset. *Three patients in initial pneumonia 
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Symptom onset to positive chest radiograph (days)
Initial pneumonia group
Positive conversion group
Table 4. Location of Novel Coronavirus Disease 2019 
Pneumonia on Chest Radiographs
Location of Pneumonia n (%)
Left upper zone 11 (8.6)
Left mid zone 40 (31.3)
Left lower zone 72 (56.3)
Right upper zone 12 (9.4)
Right mid zone 42 (32.8)
Right lower zone 88 (68.8)
Involving both lower zones 50 (39.1)
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